510(k) Report

510(k) · Cleared

Cleared

Injection Needle

K260262510(k) TraditionalCleared May 29, 2026121-day reviewClass II21 CFR 876.1500

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Mirco-Tech (Nanjing) Co., Ltd. · FBK Endoscopic Injection Needle, Gastroenterology-Urology

Cleared on May 29, 2026 as substantially equivalent to K150434 (Micro-Tech (Nanjing) Co., Ltd., 2015) after a 121-day review. Its family tree reaches back 3 generations to 1996.

Decided
May 29, 2026
Review
121 days
Class
Class II
Product code
FBK
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K955558 (1996). No later device cites it as a predicate yet.

  1. Root · 3 generations backK955558 Gip/Medi-Globe Sclerotherapy NeedlesMedi-Globe Corp. · 1996
  2. 2 generations backK061222 Injectra Injection NeedleMedi-Globe Corp. · 2006
  3. 1 generation backK150434 Injection NeedleMicro-Tech (Nanjing) Co., Ltd. · 2015
  4. This deviceK260262 Injection NeedleMirco-Tech (Nanjing) Co., Ltd. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K955558Gip/Medi-Globe Sclerotherapy NeedlesMedi-Globe Corp.1996—
−2K061222Injectra Injection NeedleMedi-Globe Corp.2006—
−1K150434Injection NeedleMicro-Tech (Nanjing) Co., Ltd.2015—
0 (this device)K260262Injection NeedleMirco-Tech (Nanjing) Co., Ltd.2026—
FIG. 1 — Lineage of K260262, 1996–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FBK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FBK device

  1. #1 K253598 InjecSURE Injection Systemscore 12.9 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K150434Injection Needle
Summary page 5
…r 876.1500 Product Code(s) FBK | Legally Marketed Predicate Devices 21 CFR 807.92(a)(3) Predicate # Predicate Trade Name (Primary Predicate is listed first) Product Code K150434 Injection Needle FBK K171454 (reference) | | Interject Injection Therapy Needle Catheter (reference device FBK only) Device Descr…
Micro-Tech (Nanjing) Co., Ltd.2015—
†K171454Interject Injection Therapy Needle CatheterBoston Scientific Corporation20172

Also cleared against K150434: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 30 years and passes through 3 companies; a new generation was cleared every 10.3 years on median.
  • None of the 3 ancestors has a recall.
  • 3 other devices also cite its predicate K150434.

How does its category compare?

All FBK devices

FBK Endoscopic Injection Needle, Gastroenterology-Urology: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · FBK

3in 2025

2008: 12009: 42011: 12012: 22014: 22015: 32016: 22017: 32018: 22019: 12020: 22021: 12022: 62023: 32024: 42025: 32026 (partial year): 2
2007high 6 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FBK

155in 2025

2009: 101 days median2015: 103 days median2017: 51 days median2022: 213 days median2023: 177 days median2024: 192 days median2025: 155 days median
2007high 213 (2022) · low 51 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FBK

9in 2024

2016: 12021: 202022: 82023: 12024: 92026 (partial year): 1
2007high 20 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FBK

81in 2025

2007: 32008: 222009: 122010: 122011: 22012: 22013: 32014: 92015: 42016: 182017: 272018: 92019: 62020: 252021: 342022: 802023: 602024: 942025: 81
2007high 94 (2024) · low 2 (2011)2025

MAUDE reports naming product code FBK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—03
20081—022
20094101012
20100—012
20111—02
20122—02
20130—03
20142—09
2015310304
20162—118
2017351027
20182—09
20191—06
20202—025
20211—2034
20226213880
20233177160
20244192994
20253155081
20262—1—

What is it indicated for?

The injection needle is intended for use in conjunction with an endoscope to perform endoscopic injections,

such as for the treatment of esophageal and gastric varies and for submucosal dye marking in the Gl tract.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K260262: Injection Needle.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K260262

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026